BRAF and colorectal carcinoma: Liebs et al. [148] utilized droplet digital PCR (ddPCR) to detect common KRAS and BRAF point mutations in plasma; however, their findings indicated that detection was only sporadically successful in a cohort of stage I–III CRC patients.